bliss-gvs-pharma-ltd
Home
Bliss GVS Pharma Ltd
BLISSGVS Share Price
BSE:
NSE:BLISSGVS
BLISSGVS Share Price
BSE:
NSE:BLISSGVS
Pharmaceuticals
Small Cap
₹-
0 (0%)
Market Cap
₹1,852.87 Cr
PE Ratio
22.01
Bliss GVS Pharma Ltd Performance
▲
▲
▲
▲
Bliss GVS Pharma Ltd Fundamentals
Bliss GVS Pharma Ltd Delivery and Volume
About Bliss GVS Pharma Ltd
Bliss GVS Pharma Limited was originally incorporated as a Private Limited Company in the name of Bliss Chemicals & Pharmaceuticals India Private Limited in 1984. The status converted into a Public Limited Company and the name of the Company was changed to Bliss Chemicals & Pharmaceuticals India Limi
| Name | Designation |
|---|---|
| Vibha G Sharma | Whole-time Director |
| Shruti Vishal Rao | Whole-time Director |
| Santosh Parab | Non-Exec. & Independent Dir. |
| Aditi Bhatt | Company Sec. & Compli. Officer |
| Shilpa Bhatia | Non-Exec. & Independent Dir. |
| Gagan Harsh Sharmma | Managing Director |
| Nandkumar Kashinath Chodankar | Chairman |
News and Events...
Top Gainers Today
View All
Top Losers Today
View All
Bliss GVS Pharma Ltd FAQs
How do I Buy Bliss GVS Pharma Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase Bliss GVS Pharma Ltd shares in BlinkX.
What is the Share Price of Bliss GVS Pharma Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. Bliss GVS Pharma Ltd's share price is ₹176.25 as of 2024-12-13.
What is the PE ratio of Bliss GVS Pharma Ltd?
Bliss GVS Pharma Ltd's P/E ratio is 22.01 times as of 2024-12-13.
What is the PB ratio of Bliss GVS Pharma Ltd?
Bliss GVS Pharma Ltd's most recent financial reports indicate a price-to-book ratio of 1.83, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of Bliss GVS Pharma Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Bliss GVS Pharma Ltd's market capitalization is ₹1852.87 Cr as on 2024-12-13.
What is the ROE of Bliss GVS Pharma Ltd?
The current financial records of Bliss GVS Pharma Ltd show a 7.91% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of Bliss GVS Pharma Ltd?
According to Bliss GVS Pharma Ltd's most recent financial filings, the company has a total asset value of ₹797.3, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of Bliss GVS Pharma Ltd?
The 52-week high/low price of a Bliss GVS Pharma Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Bliss GVS Pharma Ltd's 52-week high and low as of 2024-12-13 are ₹179.8 and ₹165, respectively.
